Press releases

All press releases Regulatory

Press release 2021-08-30

All participants in Xspray Pharma studies have received their dose of generic version of dasatinib, HyNap-Dasa ANDA

Press release 2021-08-06

Xspray Pharma has initiated studies with generic version of dasatinib, HyNap-Dasa ANDA

Regulatory press release 2021-08-06

Xspray Pharma publishes interim report Q2 , January – June 2021

Regulatory press release 2021-07-28

Xspray Pharma announces achievement of bioequivalence compared with reference product from bioequivalence study with HyNap-Dasa 505(b)(2)

Press release 2021-06-28

All participants in Xspray Pharma’s study have received their dose of the improved version of dasatinib

Press release 2021-06-23

Xspray Pharma’s two incentive programs are fully subscribed

Press release 2021-06-10

Xspray Pharma commences study with improved version of dasatinib

Regulatory press release 2021-05-20

Bulletin from the annual general meeting of Xspray Pharma AB (publ)

Regulatory press release 2021-05-06

Xspray Pharma publishes Interim Report Q1, January – March 2021

Regulatory press release 2021-04-20

Notice of annual general meeting of Xspray Pharma AB (publ)